We suggest that STS through the antioxidant activity could inhibit angiotensin II/angiotensin type 1 receptor/NADPH oxidase gp91(phox) signaling mediated ROS production, vasoconstriction, inflammation and fibrosis in renovascular hypertension model [13]. The gene discussed is FMO5; the disease is renovascular hypertension.